Menu

Filtros : " IFSC111" "Financiamento Bill and Melinda Gates Foundation Grand Challenges Explorations" Removidos: "Suécia" "vm" Limpar

Filtros

Refine with date range

  • 1

1 - 2 (2 records)

  • Artigo de periodico

    Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183 (2022)

    Vries, Laura E. ; Aguiar, Anna Caroline Campos ; Guido, Rafael Victorio Carvalho

    Source: Nature Communications. Unidade: IFSC

    Subjects: PLASMODIUM FALCIPARUM, PLANEJAMENTO DE FÁRMACOS, ANTIPARASITÁRIOS, MALÁRIA

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      VRIES, Laura E. e AGUIAR, Anna Caroline Campos e GUIDO, Rafael Victorio Carvalho. Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183. Nature Communications, v. 13, p. 2158-1-2158-16, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41467-022-29688-5. Acesso em: 08 ago. 2024.

    • APA

      Vries, L. E., Aguiar, A. C. C., & Guido, R. V. C. (2022). Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183. Nature Communications, 13, 2158-1-2158-16. doi:10.1038/s41467-022-29688-5

    • NLM

      Vries LE, Aguiar ACC, Guido RVC. Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183 [Internet]. Nature Communications. 2022 ; 13 2158-1-2158-16.[citado 2024 ago. 08 ] Available from: https://doi.org/10.1038/s41467-022-29688-5

    • Vancouver

      Vries LE, Aguiar ACC, Guido RVC. Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183 [Internet]. Nature Communications. 2022 ; 13 2158-1-2158-16.[citado 2024 ago. 08 ] Available from: https://doi.org/10.1038/s41467-022-29688-5

  • Artigo de periodico

    Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors (2021)

    Okaniwa, Masanori; Aguiar, Anna Caroline Campos; Guido, Rafael Victorio Carvalho

    Source: ACS Infectious Diseases. Unidade: IFSC

    Subjects: PLASMODIUM, MALÁRIA, ANTIMALÁRICOS, ANTIPARASITÁRIOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      OKANIWA, Masanori e AGUIAR, Anna Caroline Campos e GUIDO, Rafael Victorio Carvalho. Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors. ACS Infectious Diseases, v. 7, n. 6, p. 1680-1689, 2021Tradução . . Disponível em: https://doi.org/10.1021/acsinfecdis.1c00020. Acesso em: 08 ago. 2024.

    • APA

      Okaniwa, M., Aguiar, A. C. C., & Guido, R. V. C. (2021). Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors. ACS Infectious Diseases, 7( 6), 1680-1689. doi:10.1021/acsinfecdis.1c00020

    • NLM

      Okaniwa M, Aguiar ACC, Guido RVC. Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors [Internet]. ACS Infectious Diseases. 2021 ; 7( 6): 1680-1689.[citado 2024 ago. 08 ] Available from: https://doi.org/10.1021/acsinfecdis.1c00020

    • Vancouver

      Okaniwa M, Aguiar ACC, Guido RVC. Repositioning and characterization of 1‑(Pyridin-4-yl)pyrrolidin-2- one derivatives as plasmodium cytoplasmic prolyl-tRNA synthetase inhibitors [Internet]. ACS Infectious Diseases. 2021 ; 7( 6): 1680-1689.[citado 2024 ago. 08 ] Available from: https://doi.org/10.1021/acsinfecdis.1c00020
  • 1

1 - 2 (2 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024